Bill Text: HI HB1181 | 2017 | Regular Session | Amended
Bill Title: Relating To Workers' Compensation Prescription Drug Reimbursement.
Spectrum: Partisan Bill (Democrat 4-0)
Status: (Engrossed - Dead) 2017-03-22 - Report adopted; Passed Second Reading, as amended (SD 1) and referred to JDL/WAM. [HB1181 Detail]
Download: Hawaii-2017-HB1181-Amended.html
|
HOUSE OF REPRESENTATIVES |
H.B. NO. |
1181 |
|
TWENTY-NINTH LEGISLATURE, 2017 |
H.D. 1 |
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO WORKERS' COMPENSATION PRESCRIPTION DRUG REIMBURSEMENT.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. This Act further amends Act 231, Session Laws of Hawaii 2014, which enacted a new statutory section with the purpose of curtailing alarming cost increases of prescription drugs and compounds in the workers' compensation system. Since Act 231 was enacted, further analysis of other states shows that of the thirty-seven states that reimburse prescription drugs on the basis of a percentage of average wholesale price, the reimbursement rates range widely. Notably, Hawaii has the highest reimbursement rate for brand name and generic drugs at forty per cent over average wholesale price.
The national average reimbursement rate is three per cent below average wholesale price plus a $4.32 dispensing fee for brand name drugs and four per cent below average wholesale price plus a $4.94 dispensing fee for generic drugs. More specifically, California reimburses at a rate of seventeen per cent below average wholesale price with a $7.25 dispensing fee for both brand name and generic drugs. Oregon reimburses at 16.5 per cent below average wholesale price with a $2 dispensing fee for both brand name and generic drugs. Both these states are considered progressive workers' compensation states and have worked on their systems extensively. Louisiana has the next highest rate at ten per cent over average wholesale price with a $10.51 dispensing fee for brand name drugs.
The purpose of this Act is to bring Hawaii closer to the rest of the nation in terms of its dispensing policies and reimbursement rates for prescription drugs and compounds in the workers' compensation system.
SECTION 2. Section 386-21.7, Hawaii Revised Statutes, is amended by amending subsections (a) through (d) to read as follows:
"(a) Notwithstanding any other
provision to the contrary, immediately after a work injury is sustained by an
employee and so long as reasonably needed, the employer shall furnish to the
employee all prescription drugs as the nature of the injury requires[.];
except that physician-dispensed prescription drugs shall only be
provided during the first days from the date of
injury. The liability for the prescription drugs shall be subject to the
deductible under section 386-100.
(b) Payment for all forms of prescription
drugs including repackaged and relabeled drugs shall be [one hundred forty]
ninety per cent of the average wholesale price set by the original
manufacturer of the dispensed prescription drug as identified by its National
Drug Code and as published in the Red Book: Pharmacy's Fundamental Reference
as of the date of dispensing, except where the employer or carrier, or any
entity acting on behalf of the employer or carrier, directly contracts with the
provider or the provider's assignee for a lower amount.
(c) Payment for compounded prescription drugs
shall be the sum of [one hundred forty] ninety per cent of the
average wholesale price by gram weight of each underlying prescription drug
contained in the compounded prescription drug. For compounded prescription
drugs, the average wholesale price shall be that set by the original
manufacturer of the underlying prescription drug as identified by its National
Drug Code and as published in the Red Book: Pharmacy's Fundamental Reference
as of the date of compounding, except where the employer or carrier, or any
entity acting on behalf of the employer or carrier, directly contracts with the
provider or provider's assignee for a lower amount.
(d) All pharmaceutical claims submitted for
repackaged, relabeled, or compounded prescription drugs shall include the
National Drug Code of the original manufacturer. If the original manufacturer
of the underlying drug product used in repackaged, relabeled, or compounded
prescription drugs is not provided or is unknown, then reimbursement shall be [one
hundred forty] ninety per cent of the average wholesale price for
the original manufacturer's National Drug Code number as listed in the Red
Book: Pharmacy's Fundamental Reference of the prescription drug that is most
closely related to the underlying drug product."
SECTION 3. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 4. This Act shall take effect on July 1, 2050.
Report Title:
Workers' Compensation; Prescription Drugs; Reimbursement; Limitation
Description:
Amends the reimbursement rate for prescription drugs in the workers' compensation system to be ninety per cent of the average wholesale price. Restricts the provision of physician-dispensed prescription drugs to an unspecified time following injury. (HB1181 HD1)
The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
